Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP612802.RAkFG9lkAaB5UlvkELTxSDdQol6nYajjv9-gZXaT-wdiQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP612802.RAkFG9lkAaB5UlvkELTxSDdQol6nYajjv9-gZXaT-wdiQ130_assertion type Assertion NP612802.RAkFG9lkAaB5UlvkELTxSDdQol6nYajjv9-gZXaT-wdiQ130_head.
- NP612802.RAkFG9lkAaB5UlvkELTxSDdQol6nYajjv9-gZXaT-wdiQ130_assertion wasGeneratedBy ECO_0000203 NP612802.RAkFG9lkAaB5UlvkELTxSDdQol6nYajjv9-gZXaT-wdiQ130_provenance.
- NP612802.RAkFG9lkAaB5UlvkELTxSDdQol6nYajjv9-gZXaT-wdiQ130_assertion wasDerivedFrom befree-20150227 NP612802.RAkFG9lkAaB5UlvkELTxSDdQol6nYajjv9-gZXaT-wdiQ130_provenance.
- NP612802.RAkFG9lkAaB5UlvkELTxSDdQol6nYajjv9-gZXaT-wdiQ130_assertion SIO_000772 16510596 NP612802.RAkFG9lkAaB5UlvkELTxSDdQol6nYajjv9-gZXaT-wdiQ130_provenance.
- NP612802.RAkFG9lkAaB5UlvkELTxSDdQol6nYajjv9-gZXaT-wdiQ130_assertion evidence source_evidence_literature NP612802.RAkFG9lkAaB5UlvkELTxSDdQol6nYajjv9-gZXaT-wdiQ130_provenance.
- NP612802.RAkFG9lkAaB5UlvkELTxSDdQol6nYajjv9-gZXaT-wdiQ130_assertion description "[Because combined treatment with anti-TfR mAbs resulted in the up-regulation of the hypoxia pathway, which may increase tumor angiogenesis, we analyzed the effects of ascorbate on cell viability and HIF-1alpha levels in cells treated with both anti-TfR mAbs together, as ascorbate has been shown to be required by PHD enzymes for full catalytic activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP612802.RAkFG9lkAaB5UlvkELTxSDdQol6nYajjv9-gZXaT-wdiQ130_provenance.